dromlakhani Individualized Management Approach Based on Postoperative Serum Cortisol Categorization
STEP 1 — Gather Information
Collect postoperative morning serum cortisol (drawn before any glucocorticoid dose, preferably postoperative day 1), assess for symptoms of hypocortisolism (fatigue, nausea, hypotension) or hypercortisolism (hypertension, hyperglycemia), and note any exogenous glucocorticoid administration. Proceed to cortisol threshold evaluation.
STEP 2 — Rule In / Rule Out
Is postoperative morning serum cortisol <5 µg/dL? If yes, classify as hypocortisolism; if no, proceed to evaluate for hypercortisolism.
STEP 3 — Classify or Stratify
For cortisol ≥5 µg/dL, determine if >20 µg/dL; if yes, classify as hypercortisolism; if 5–20 µg/dL, classify as eucortisolism.
STEP 4 — Decide
For hypocortisolism: initiate physiologic glucocorticoid replacement (hydrocortisone 10–12 mg/m²/d in divided doses) and educate on stress dosing; taper based on HPA recovery. For hypercortisolism: consider additional definitive therapy (repeat surgery, medical therapy, bilateral adrenalectomy, or radiation) based on persistence and patient factors. For eucortisolism: if on glucocorticoids, attempt taper; monitor with late-night salivary cortisol or UFC every 3–6 months to detect recurrence.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on a single random cortisol; ensure fasting AM sample; avoid interpreting cortisol while on exogenous glucocorticoids. Do not taper replacement prematurely before HPA axis recovery. Recognize assay variability and stress can shift values. Use late-night salivary cortisol or UFC to confirm eucortisolism. Watch for adrenal crisis in hypocortisolism.
Concrete Clinical Example
A 48-year-old man with Cushing disease underwent transsphenoidal adenomaectomy. POD1 morning cortisol was 4 µg/dL (<5 µg/dL). He reported mild fatigue and hypotension. He was started on hydrocortisone 10 mg/m²/d in divided doses, given stress-dosing education, and tapered over 8 months as morning cortisol rose to 12 µg/dL and ACTH stimulation test normalized.
Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, https://doi.org/10.1210/jc.2015-1818